Back to Search
PHILLIP CHIAO, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1376641464Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
49131(CA)
Research & Publications (20)
Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells.
PMID 12365017·Cancer·2002
8-other
Combination chemotherapy of nafamostat mesilate with gemcitabine for pancreatic cancer targeting NF-kappaB activation.
PMID 19661331·Anticancer Res·2009
7-preclinical
Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB.
PMID 19435817·Mol Cancer Res·2009
7-preclinical
LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis.
PMID 18413796·Mol Cancer Ther·2008
7-preclinical
Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death.
PMID 17613437·Cancer Cell·2007
7-preclinical
Inhibition of nuclear factor-kappaB augments antitumor activity of adenovirus-mediated melanoma differentiation-associated gene-7 against lung cancer cells via mitogen-activated protein kinase kinase kinase 1 activation.
PMID 17431123·Mol Cancer Ther·2007
7-preclinical
Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models.
PMID 17613436·Cancer Cell·2007
7-preclinical
Keratinocyte growth factor/fibroblast growth factor-7-regulated cell migration and invasion through activation of NF-kappaB transcription factors.
PMID 17200110·J Biol Chem·2007
7-preclinical
Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
PMID 17410536·Cancer·2007
8-other
Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway.
PMID 17158870·J Biol Chem·2007
7-preclinical
Src activation of Stat3 is an independent requirement from NF-kappaB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells.
PMID 16871430·Angiogenesis·2006
8-other
Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma.
PMID 16951171·Cancer Res·2006
8-other
Inactivation of IkappaB contributes to transcriptional activation of spermidine/spermine N(1)-acetyltransferase.
PMID 16637064·Mol Carcinog·2006
8-other
Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells.
PMID 16585204·Cancer Res·2006
7-preclinical
Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate.
PMID 16959615·Cancer Cell·2006
7-preclinical
Regulation of nuclear translocation of HDAC3 by IkappaBalpha is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor gamma function.
PMID 16371367·J Biol Chem·2006
7-preclinical
Induction of apoptosis in tumor-associated endothelial cells and therapy of orthotopic human pancreatic carcinoma in nude mice.
PMID 16026649·Neoplasia·2005
7-preclinical
Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer.
PMID 16204081·Cancer Res·2005
7-preclinical
Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells.
PMID 16357160·Cancer Res·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4150 CLEMENT ST
SAN FRANCISCO, CA 94121 - Phone
- (415) 221-4810
Quick Facts
- NPI
- 1376641464
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile